This embodiment is used in combination with small peptides-based compounds were further active agents, such as benign tumors or malignant tumors, including a method of treating a medical condition that requires removal or destruction of cellular elements . This method, intramuscular the compound, oral, intravenous, intrathecal, prostate, intratumorally, intranasally, topically, transdermally, etc., administering it in linkage to a alone or carrier to a mammal in need It includes, but is not limited thereto.